Its portfolio of products, marketed under the brand name Plenachol® Capsules are licensed in the United Kingdom, and are undergoing regulatory review in a number of other global territories, for the prevention and treatment of vitamin D deficiency in children and adults. D3 Pharma’s products have been developed over many years of research and development, culminating in the only range of high-dose vitamin D3 products that have granted patents in the United Kingdom and in Europe, with its patents pending in a number of other global territories.
D3 Pharma’s products utilise a unique formulation base which is fully Kosher and Halal Certified and is suitable for Vegetarians.
D3 Pharma’s pioneering work in the vitamin D area has addressed a significant unmet medical need and has provided medical specialists, general physicians and healthcare professionals worldwide with much improved access to high-dose vitamin D3 products.